FarsNewsAgency - خبرگزاري فارس
Turkish / Persian / Arabic / English 4  Sha'ban  1434 /  Thursday 13 Jun 2013 / 23 Khordad 1392 a
Tehran - 06:59 / GMT - 02:29

Mainpage


All Stories

Politics
Economy
Social
World
Culture
Foreign Policy
Nuclear
Sports
Science
Art
Defence
Interview
Commentary
Photo


Search

Contact us

About us


News number: 9203180222

18:30 | 2013-06-08

Science

Printable Version Send to a friend

Iran Unveils 3 New Medicines

TEHRAN (FNA)- Iranian Minister of Science, Research and Technology Kamran Daneshjou on Saturday unveiled three new drugs produced by Iranian scientists at Razi University in the western Kermanshah province.



The three drugs named Minoxidil, Monte Lucas and Thiopental Sodium are used to treat blood pressure (hypertension), chronic asthma and post-anesthesia convulsion, respectively.

The medications were imported into the country from the foreign states before.

Iran has taken wide strides in science and technology, particularly in medical and medicinal fields, in recent years.

Iranian President Mahmoud Ahmadinejad unveiled five new home-made radiomedicines in a ceremony in April.

The radiomedicines were developed and produced by Iranian experts at the Atomic Energy Organization of Iran (AEOI) and with the cooperation of the presidential office for science and technology.

Also in April, Iranian Vice-President for Science and Technology Nasrin Soltankhah said, "Five radiomedicines, in whose production the Atomic Energy Organization has played the central role, will be unveiled by the end of Farvardin (mid April)".

She explained that the new radiomedicines are used for "diagnosing and curing refractory diseases, cancer in particular".

In February, AEOI Chief Fereidoun Abbasi announced that Iran is due to unveil 8 new radiomedicines with applications for diagnosis, prevention and treatment of a number of diseases.

"We have produced a number of radiomedicines before, and at present we have 5 new radiomedicines under production," Abbasi said at a ceremony in Tehran at the time.

"They (the new radiomedicines) should pass clinical verifications and then obtain the necessary license from the Health Ministry before they can be unveiled and supplied to the market," he added.